ST segment elevation myocardial infarction
Information
- Disease name
- ST segment elevation myocardial infarction
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01435408 | Active, not recruiting | N/A | DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction | April 2011 | December 2024 |
| NCT01495364 | Completed | Phase 2 | NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction | December 2011 | April 2016 |
| NCT01538303 | Completed | Microvascular Dysfunction in Acute Myocardial Infarction (AMI) and Its Relation to Outcome | March 2012 | October 2012 | |
| NCT01336348 | Completed | Phase 3 | Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse | April 2010 | June 2012 |
| NCT01897350 | Completed | Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial | July 2013 | ||
| NCT02026219 | Completed | Phase 4 | Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction | October 2013 | December 2014 |
| NCT02498405 | Completed | Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction | December 2015 | ||
| NCT03234348 | Completed | Phase 3 | MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction | July 1, 2017 | October 31, 2019 |
| NCT03247738 | Completed | Phase 4 | Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI | November 20, 2017 | December 13, 2018 |
| NCT03296670 | Completed | Phase 4 | Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP | August 1, 2015 | August 31, 2017 |
| NCT03565978 | Completed | N/A | Cardiac Care Solution for Coronary Disease Follow up | April 8, 2016 | July 30, 2018 |
| NCT03780335 | Completed | Early Prediction of QFR in STEMI-I | January 1, 2015 | September 30, 2018 | |
| NCT05705089 | Completed | Phase 3 | Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI | July 30, 2020 | April 1, 2023 |
| NCT05461781 | Recruiting | N/A | Distal Transradial Access for Primary PCI in STEMI Patients to Prevent RAO | May 10, 2022 | December 30, 2024 |
| NCT03508232 | Recruiting | Phase 2 | Doxycycline to Protect Heart Muscle After Heart Attacks | January 6, 2020 | December 31, 2024 |
| NCT03787745 | Recruiting | N/A | Ischemic Postconditioning in STEMI Patients Treated With Primary PCI | February 4, 2019 | January 31, 2033 |
| NCT03764241 | Recruiting | Phase 3 | Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant | February 1, 2020 | December 30, 2023 |
| NCT03561389 | Unknown status | iFR-guided Revascularization in STEMI | May 1, 2018 | March 31, 2020 | |
| NCT04220736 | Unknown status | Early Prediction of QFR in STEMI-Pharmaco-invasice | January 1, 2018 | July 25, 2020 | |
| NCT03621111 | Unknown status | N/A | A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction | February 19, 2018 | August 19, 2019 |
| NCT03735719 | Unknown status | Biomarkers for Risk Stratification After STEMI | April 2014 | January 2021 | |
| NCT03753269 | Unknown status | Phase 4 | Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction | July 1, 2019 | December 30, 2022 |
| NCT01716884 | Unknown status | China STEMI-PCI Program | December 2011 | June 2016 | |
| NCT02495012 | Unknown status | Phase 2 | Anfibatide Treatment in STEMI Patients | August 2015 | May 2016 |
| NCT03786757 | Unknown status | Phase 3 | Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) | April 1, 2019 | December 30, 2022 |
| NCT02869906 | Unknown status | Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Non Culprit Lesions in Patients With ST-segment Elevation Myocardial Infarction | September 2015 | December 2016 | |
| NCT02979236 | Unknown status | Italian Multi-center Registry of Self-apposing Coronary Stent in Patients With STEMI | June 2016 | ||
| NCT03252665 | Unknown status | Phase 4 | Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI | September 1, 2017 | June 30, 2019 |
| NCT03895983 | Unknown status | ST Segment Resolution After Primary Percutaneous Coronary Intervention. | September 1, 2019 | September 1, 2021 | |
| NCT03910400 | Unknown status | N/A | Early Assessment of QFR in STEMI-II | February 1, 2019 | March 1, 2021 |
| NCT03406819 | Unknown status | N/A | Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI | January 7, 2018 | December 31, 2019 |
| NCT03406832 | Unknown status | N/A | Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI | January 8, 2018 | December 31, 2019 |